1. Home
  2. RYTM vs TEX Comparison

RYTM vs TEX Comparison

Compare RYTM & TEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYTM
  • TEX
  • Stock Information
  • Founded
  • RYTM 2008
  • TEX 1933
  • Country
  • RYTM United States
  • TEX United States
  • Employees
  • RYTM N/A
  • TEX N/A
  • Industry
  • RYTM Biotechnology: Pharmaceutical Preparations
  • TEX Construction/Ag Equipment/Trucks
  • Sector
  • RYTM Health Care
  • TEX Industrials
  • Exchange
  • RYTM Nasdaq
  • TEX Nasdaq
  • Market Cap
  • RYTM 3.2B
  • TEX 3.0B
  • IPO Year
  • RYTM 2017
  • TEX N/A
  • Fundamental
  • Price
  • RYTM $52.70
  • TEX $37.50
  • Analyst Decision
  • RYTM Strong Buy
  • TEX Hold
  • Analyst Count
  • RYTM 12
  • TEX 10
  • Target Price
  • RYTM $68.58
  • TEX $54.22
  • AVG Volume (30 Days)
  • RYTM 544.5K
  • TEX 1.2M
  • Earning Date
  • RYTM 05-06-2025
  • TEX 04-24-2025
  • Dividend Yield
  • RYTM N/A
  • TEX 1.77%
  • EPS Growth
  • RYTM N/A
  • TEX N/A
  • EPS
  • RYTM N/A
  • TEX 4.96
  • Revenue
  • RYTM $130,126,000.00
  • TEX $5,127,000,000.00
  • Revenue This Year
  • RYTM $47.06
  • TEX $6.38
  • Revenue Next Year
  • RYTM $68.10
  • TEX $4.14
  • P/E Ratio
  • RYTM N/A
  • TEX $7.76
  • Revenue Growth
  • RYTM 68.06
  • TEX N/A
  • 52 Week Low
  • RYTM $35.17
  • TEX $36.15
  • 52 Week High
  • RYTM $68.58
  • TEX $68.08
  • Technical
  • Relative Strength Index (RSI)
  • RYTM 48.00
  • TEX 37.25
  • Support Level
  • RYTM $52.54
  • TEX $37.98
  • Resistance Level
  • RYTM $55.21
  • TEX $41.34
  • Average True Range (ATR)
  • RYTM 2.05
  • TEX 1.40
  • MACD
  • RYTM 0.36
  • TEX 0.20
  • Stochastic Oscillator
  • RYTM 47.82
  • TEX 14.58

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

About TEX Terex Corporation

Terex is a top manufacturer of aerial work platforms, materials processing equipment, and specialty equipment, such as material handlers, cranes, and concrete mixer trucks. Its current composition is a result of numerous acquisitions over several decades and a recent shift to focus on its two core segments after divesting a handful of underperforming businesses. Terex's remaining segments see heavy demand in nonresidential construction as well as in maintenance, manufacturing, energy, and materials management.

Share on Social Networks: